IRIS PubliCatt
PubliCatt è il repository istituzionale ad accesso aperto dell'Università Cattolica del Sacro Cuore, dove gli utenti autorizzati afferenti all'Ateneo provvedono direttamente e autonomamente a depositare e a rendere visibili le proprie pubblicazioni, inserendo i dati descrittivi del documento stesso ("metadati", quali il titolo, autore, abstract, etc.) e, laddove possibile, il testo della pubblicazione stessa (full-text).
PubliCatt utilizza la piattaforma IRIS (Institutional Research Information System) sviluppata da CINECA.
EnglishEpidermal growth factor receptor (EGFR) overexpression and prognostic value in head and neck squamous cell cancer is the basis for targeting by anti-EGFR antibodies, which increase the efficacy of radiotherapy. In order to evaluate the best therapeutic schedule, the effects of cetuximab (C225) on Hep-2 cell proliferation, alone and in combination with cisplatin, were studied.
Bussu, F., Pozzoli, G., Giglia, V., Rizzo, D., Limongelli, A., De Corso, E., Graziani, C., Paludetti, G., Navarra, P., Almadori, G., Effects of the administration of epidermal growth factor receptor specific inhibitor cetuximab, alone and in combination with cisplatin, on proliferation and apoptosis of Hep-2 laryngeal cancer cells, <<JOURNAL OF LARYNGOLOGY AND OTOLOGY>>, 2014; 128 (10): 902-908. [doi:10.1017/S002221511400190X] [http://hdl.handle.net/10807/60258]
| Autori: | |
| Titolo: | Effects of the administration of epidermal growth factor receptor specific inhibitor cetuximab, alone and in combination with cisplatin, on proliferation and apoptosis of Hep-2 laryngeal cancer cells |
| Digital Object Identifier (DOI): | http://dx.doi.org/10.1017/S002221511400190X |
| Data di pubblicazione: | 2014 |
| Abstract: | Epidermal growth factor receptor (EGFR) overexpression and prognostic value in head and neck squamous cell cancer is the basis for targeting by anti-EGFR antibodies, which increase the efficacy of radiotherapy. In order to evaluate the best therapeutic schedule, the effects of cetuximab (C225) on Hep-2 cell proliferation, alone and in combination with cisplatin, were studied. |
| Lingua: | Inglese |
| Rivista: | |
| Citazione: | Bussu, F., Pozzoli, G., Giglia, V., Rizzo, D., Limongelli, A., De Corso, E., Graziani, C., Paludetti, G., Navarra, P., Almadori, G., Effects of the administration of epidermal growth factor receptor specific inhibitor cetuximab, alone and in combination with cisplatin, on proliferation and apoptosis of Hep-2 laryngeal cancer cells, <<JOURNAL OF LARYNGOLOGY AND OTOLOGY>>, 2014; 128 (10): 902-908. [doi:10.1017/S002221511400190X] [http://hdl.handle.net/10807/60258] |
| Appare nelle tipologie: | Articolo in rivista, Nota a sentenza |
File in questo prodotto:
Copyright © 2021